Head-to-head · Cost-Efficiency Index
Candor Rx vs GOAL.MD
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Candor Rx
Cost-first shoppers who want flat-rate compounded GLP-1 with broad 49-state coverage.
Visit Candor RxGOAL.MD
Shoppers comparing a named physician-led practice, who won't mistake the $149 ad price for the ongoing rate.
Visit GOAL.MDThe verdict
Candor Rx takes it, leading the Cost-Efficiency Index 72 to 71. Candor Rx sells compounded semaglutide from $99/month and tirzepatide from $149/month, both flat regardless of dose, with no membership fee disclosed and a cancel-anytime, full-refund-if-not-prescribed policy. GOAL.MD still earns a C — Shoppers comparing a named physician-led practice, who won't mistake the $149 ad price for the ongoing rate.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Candor Rx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Candor Rx | GOAL.MD |
|---|---|---|
| Cost-Efficiency Index | 72/100 | 71/100 |
| Semaglutide / mo | $99/mo | $199/mo (promotional rate, compounded) |
| Tirzepatide / mo | $149/mo | $299/mo (compounded) |
| Semaglutide / yr (modeled) | $1,188 | $2,388 |
| Tirzepatide / yr (modeled) | $1,788 | $3,588 |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Yes |
| Rank here | #74 | #81 |
Candor Rx
72/100Where the value is
- Flat, dose-independent pricing confirmed on both drug sections — no dose-based upcharge
- Cancel anytime with a full refund if the physician can't prescribe
- Names a specific compounding pharmacy (Manifest Pharmacy, Greer, SC) rather than an anonymous claim
The tradeoffs
- The site's own $95/month hero banner does not match either real price — semaglutide is actually $99 and tirzepatide $149, a headline-vs-actual mismatch a shopper could easily be misled by
- No named medical director or individual prescriber — only 'US-based doctors'
GOAL.MD
71/100Where the value is
- Named Chief Physician (Dr. Michael Mimlitz, MD) rather than an anonymous provider network
- Multiple product tiers (standard, micro-dose, combination 'Synergy') for different budgets and needs
- 3-month bundle discount available on the combination product ($547/mo vs. $597/mo single-month)
The tradeoffs
- The widely advertised '$149' price is a first-month-only discount; the standing rate is $199/mo semaglutide and $299/mo tirzepatide — more than double the headline for tirzepatide
- No named compounding pharmacy — only generic '503A & 503B licensed U.S. pharmacies' language
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.